socalTECH

NOVEMBER 13, 2019

San Diego-based COI Pharmaceuticals , the life sciences incubator and support entity created by Avalon Ventures to support its portfolio companies, says that one of its companies, Calporta Therapeutics , has been acquired by Merck. The deal is worth up to $576M, including upfront payments and contingent milestone payments. READ MORE>>.

Avalon 124

Avalon San Diego Incubator Technology 124

socalTECH

APRIL 1, 2013

San Diego-based Proximal Data , which develops serve-side caching software for accelerating I/O access to virtualized machines, said this morning that it has raised $2M in a Series B round of funding. The funding came from Divergent Ventures, along with existing investors Avalon Ventures. The firm is led by Rory Bolt. READ MORE>>.

Software 124

Software Avalon San Diego Design 124

socalTECH

JUNE 30, 2009

La Jolla-based Ortiva Wireless , which develops technology to stream video to mobile devices, reports today that it has hired on a new, Senior Vice President of Worldwide Sales, James D. Ortiva is backed by Comcast, Artiman Ventures, Mission Ventures, and Avalon Ventures. READ MORE>>.

Sales 113

Sales Avalon Mission Ventures Mobile 113

socalTECH

JULY 20, 2016

San Diego-based Synthorx , a developer of protein therapeutics technology, said it has raised $10M in a Series B financing this morning. The funding was led by RA Capital Management, and also included Avalon Ventures and Correlation Ventures. The company's technology is based on research from The Scripps Research Institute.

Avalon 100

Avalon San Diego Research Capital 100

socalTECH

NOVEMBER 18, 2008

in a Series A financing for the firm's biopharmaceuticals technology. According to the firm, the financing came from Avalon Ventures LLC. Zacharon Pharmaceutical is developing glycan inhibitors which have appications in treating genetic disorders and oncology. The firm also said it has received more than $2.2M

Avalon 100

Avalon San Diego Research Technology 100

socalTECH

MAY 27, 2009

San Diego-based E-Band Communications , a developer of millimeter-wave wireless transmission systems, said Wednesday that the firm has raised a Series C financing round. According to E-Band, the round was led by Hercules Technology Growth Capital, and also included Avalon Ventures.

Avalon 100

Avalon Funding San Diego Capital 100

socalTECH

DECEMBER 4, 2015

The funding was led by Avalon Ventures and TPG Biotech, and also included Correlation Ventures and Osage University Partners. The startup said it is developing novel drugs based on the anti-cancer activity of metformin and designed to reduce cancer energy production to treat a range of cancer types. READ MORE>>.

UCLA 100

UCLA Avalon San Diego Los Angeles 100

socalTECH

JUNE 29, 2009

San Diego-based Ambit Biosciences , a developer of small molecule profiling tools being used for biopharmaceuticals development, has raised $6.5M in an ongoing, debt round, according to a filing from the firm today. in debt, including warrants in the firm. in debt, including warrants in the firm.

Avalon 100

Avalon San Diego Venture Capital Tool 100

socalTECH

NOVEMBER 25, 2008

San Diego-based Awarepoint, a developer of systems for tracking assets and patients in hospitals, has raised $13.3M The firm said the round was led by Cardinal partners, and also included Venrock and prior investor Avalon Ventures. in a Series D funding. The firm offers its services as software-as-a-service to the healthcare industry.

Avalon 100

Avalon San Diego Funding Services 100

socalTECH

MARCH 2, 2009

La Jolla-based Ortiva Wireless , a developer of products for managing mobile video streaming, said this morning that it has signed on Mobix Interactive as a customer. Ortiva's venture backers are Artiman Ventures, Avalon Ventures, Comcast, and Mission Ventures. Financial impact of the customer win was not disclosed. READ MORE>>.

Avalon 100

Avalon Mission Ventures Demand Platform 100

socalTECH

JULY 22, 2016

San Diego-based AristaMD , which is developing software tools to help coordinate referrals by physicians to specialists, has raised $11M in a Series A funding round. The funding was led by Avalon Ventures, and also included Correlation Ventures. READ MORE>>.

Avalon 100

Avalon San Diego Tool Research 100

socalTECH

FEBRUARY 23, 2009

Irvine-based Broadcom and San Diego-based Chumby are working together to integrate Chumby's technology into set top boxes, the firms announced this morning. According to the companies, the integration of that technology onto Broadcom's digital TV chips will allow users to personalize their user experience on Internet-connected TVs.

Avalon 100

Avalon San Diego Social Network News 100

Xconomy

SEPTEMBER 27, 2016

Fortis Therapeutics, a new San Diego biotech, has raised $18 million in initial funding to develop drugs for hard-to-treat prostate and bone marrow cancers. San Diego’s Avalon Ventures led the Series A round, and has established Fortis at COI Pharma, the firm’s biotech incubator (which now houses 16 life sciences startups).

Avalon 40

Avalon Funding Startup San Diego 40

Xconomy

AUGUST 31, 2016

Roger Tsien, a UC San Diego scientist who shared the 2008 Nobel Prize in chemistry for research that led to the development of fluorescent proteins used to illuminate tissue and track biological processes, has died, according to a statement from the university. He compared himself to John C. Reprints | Share: UNDERWRITERS AND PARTNERS.

San Diego 72

San Diego UCSD Avalon Study 72

Xconomy

AUGUST 17, 2016

and San Diego’s Avalon Ventures. Avelas plans to use the new funding to advance development of AVB-620, the company’s lead diagnostic agent, for use in breast cancer surgeries, CEO Carmine Stengone told me yesterday. Avalon partner Jay Lichter plans to continue serving as Avelas’ chairman, Stengone said.

Avalon 40

Avalon San Diego Study Invest 40

Xconomy

DECEMBER 7, 2018

Synthorx, which is working to develop cancer and autoimmune therapies using technology that allows it to expand the genetic alphabet, raised $131 million in an upsized IPO on Thursday. The company sold more than 11.9 million shares at $11 apiece. million additional shares are available for its underwriters to purchase.

Technology 98

Technology Develop Development San Diego 98

Xconomy

JULY 19, 2016

Existing investors Avalon Ventures and Correlation Ventures joined in the round. An unnamed pharmaceutical company also is providing additional undisclosed funding under a drug development deal signed in February, Turner said. coli bacteria and to make proteins that incorporate synthetic amino acids.

San Diego 40

San Diego Avalon Research Examples 40

Xconomy

SEPTEMBER 30, 2016

Who will break free of the pack of companies developing drugs meant to prevent migraines? —Amgen (NASDAQ: AMGN ), of Thousand Oaks, CA, and partner Novartis released positive results from the first Phase 3 trial of erenumab , one of a group of drugs being developed to prevent migraines , not just lessen their impact when they happen.

Avalon 40

Avalon Thousand Oaks Study Startup 40

Tech Zulu Event

DECEMBER 6, 2013

The Connected Car , where automotive and technology (outside of vehicle performance and earth saving “greenness”) collide. Auto-interfaces are clunky, and when a lot of these big tech companies IPO’d, a lot of them developed products that were endemic to the car industry – navigation, social graphs, etc.

Advertising 97

Advertising Startup Marketing Mobile 97